NCT06496178
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06496178
Title A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Genmab
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NLD | LTU | ITA | ISR | HUN | GRC | GBR | FRA | ESP | DEU | CZE | CHE | CAN | BRA | BEL | AUS | ARG


No variant requirements are available.